No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
UHS240621C175000
- 13.58
- +5.81+74.77%
15min DelayClose May 31 15:59 ET
13.58High13.58Low
13.58Open7.77Pre Close1 Volume19 Open Interest175.00Strike Price1.36KTurnover23.62%IV0.40%PremiumJun 21, 2024Expiry Date14.80Intrinsic Value100Multiplier19DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type0.9419Delta0.0112Gamma12.21Leverage Ratio-0.0541Theta0.0866Rho11.50Eff Leverage0.0507Vega
Intraday
- 5D
- 1D
News
Returns On Capital At Universal Health Services (NYSE:UHS) Have Hit The Brakes
Goldman Sachs Adjusts Price Target on Universal Health Services to $200 From $189
Universal Health Services (UHS) has an average rating of outperform and price targets ranging from $156 to $226, according to analysts polled by Capital IQ. Price: 187.00, Change: +1.10, Percent Chang
Universal Health Is Maintained at Neutral by JP Morgan
Universal Health Is Maintained at Neutral by JP Morgan
Express News | JP Morgan Maintains Neutral on Universal Health Servs, Raises Price Target to $186
JPMorgan Adjusts Price Target on Universal Health Services to $186 From $182
Universal Health Services (UHS) has an average outperform rating and a price target range of $156 to $226, according to analysts polled by Capital IQ.
Universal Health Initiated at Neutral by Baird
Universal Health Initiated at Neutral by Baird
Comments
Insider selling at Universal Health Services, especially by Executive VP Steve Filton, may worry investors. Despite some insider buying, the long-term outlook isn't very positive. High insider ownership suggests management's interests align with shareholders, but insider selling warrants caution.
Universal Health Services Insiders Sold US$8.5m Of Shares Suggesting Hesitancy 1
The declining ROCE trend at Universal Health Services does not inspire confidence. Despite the company's reinvestment in its own business, returns are shrinking. Investors looking for a multi-bagger might want to consider other options.
1
The EPS decline may not reflect the business's evolution. Other metrics, like revenue growth and TSR, could be positive signs for long-term investors.
1
Universal Health Services is still a bargain according to the price multiple model. Its volatile share price could provide more buying opportunities. The company's optimistic future growth hasn't been fully factored into the share price yet.
Insider selling over the past year may worry shareholders, despite high insider ownership suggesting aligned interests. This activity raises doubts in the company's valuation.
Read more